Gyre Therapeutics (NASDAQ:GYRE) and International Stem Cell (OTCMKTS:ISCO) Head-To-Head Analysis
Volatility & Risk Gyre Therapeutics has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500. Comparatively, International Stem Cell has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500. Insider & Institutional Ownership 24.0% of Gyre Therapeutics shares are […]
Volatility & Risk Gyre Therapeutics has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500. Comparatively, International Stem Cell has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500. Insider & Institutional Ownership 24.0% of Gyre Therapeutics shares are […]
